Recursion Pharmaceuticals, Inc. - Class A Common Stock (RXRX) stock analysis

RXRX · Recursion Pharmaceuticals, Inc. - Class A Common Stock

Latest recorded price: USD 2.90

Sector and industry: Healthcare · Biotechnology

Fiscal 2025 figures: revenue growth 23.3%, free cash flow margin -506.5%, ROIC -86.4%. The model flags 1 risk signal for this company (1 high severity).

Similar companies in Healthcare